We studied 20 adult patients undergoing cardiac surgery. All received pancuronium as the sole neuromuscular blocking drug and no reversal agent was used. In the postoperative intensive care unit, mechanical ventilation was continued and patients were sedated with an infusion of propofol. Neuromuscular block was measured electromyographically at appropriate intervals until the train-of-four ratio (TOF) reached 0.8. At the time when the propofol infusion would normally be discontinued, 13 patients (65%) demonstrated a TOF of less than 0.8 (group median 0.23, interquartile range 0.11-0.6). Subsequently, the median time to achieve a TOF of 0.8 was 2 h 10 min (interquartile range 1 h-2 h 25 min). We found that if pancuronium was used during cardiac surgery, a significant proportion of patients remained partially paralysed when they would normally be allowed to emerge from anaesthesia in the ICU. 1999; 83: 338-9 Keywords: neuromuscular block, pancuronium; neuromuscular block, measurement of response; surgery, cardiovascular Accepted for publication : February 26, 1999 Several studies of patients in the postoperative period have demonstrated a high incidence (20-50%) of residual neuromuscular block after the use of long-acting neuromuscular blocking agents such as pancuronium. 1 Pancuroniuminduced residual block has been shown to be a significant risk factor for postoperative pulmonary complications. 2 Pancuronium continues to enjoy considerable popularity in cardiac anaesthetic practice. Although the patient's lungs are usually ventilated for a period of time after surgery, there is a risk that residual block may persist at the time of extubation in the intensive care unit (ICU). McEwan, Merrick and Bevan 3 demonstrated that 10 patients receiving pancuronium were all partially paralysed (TOF Ͻ0.7) on arrival in the ICU after cardiac surgery but these workers failed to make sufficient repeated measurements to establish when adequate neuromuscular function was restored.
Several studies of patients in the postoperative period have demonstrated a high incidence (20-50%) of residual neuromuscular block after the use of long-acting neuromuscular blocking agents such as pancuronium. 1 Pancuroniuminduced residual block has been shown to be a significant risk factor for postoperative pulmonary complications. 2 Pancuronium continues to enjoy considerable popularity in cardiac anaesthetic practice. Although the patient's lungs are usually ventilated for a period of time after surgery, there is a risk that residual block may persist at the time of extubation in the intensive care unit (ICU). McEwan, Merrick and Bevan 3 demonstrated that 10 patients receiving pancuronium were all partially paralysed (TOF Ͻ0.7) on arrival in the ICU after cardiac surgery but these workers failed to make sufficient repeated measurements to establish when adequate neuromuscular function was restored.
The aims of our study were to measure the extent of residual pancuronium-induced neuromuscular block at the time when patients would normally be allowed to regain full consciousness in the cardiac ICU, and to investigate the subsequent time course of spontaneous recovery from neuromuscular block until a satisfactory TOF ratio was achieved.
Methods and results
After obtaining approval from the Local Ethics Committee and informed consent, we studied 20 adult patients after © British Journal of Anaesthesia undergoing cardiac surgery requiring cardiopulmonary bypass (CPB). During surgery, all had received pancuronium as the sole neuromuscular blocking agent. The dose of pancuronium administered during anaesthesia was left to the discretion of the senior anaesthetist who was not involved in measuring neuromuscular function in the ICU. No patient had pre-existing renal or neuromuscular dysfunction. After operation, patients were sedated with a continuous i.v. infusion of propofol and the lungs were ventilated mechanically, following routine practice in the ICU. A convective warming blanket was applied until central body temperature reached 37°C.
From the time each patient arrived in the ICU, the trainof-four (TOF) ratio was measured at the adductor pollicis muscle at 5-min intervals using a diagnostic-quality electromyograph (Disa Neuromatic 2000) which stimulated the ulnar nerve with a supramaximal current. Before application of standard ECG electrodes, the patient's skin was degreased. The electrodes were covered with adhesive tape and the hand was wrapped in thermal insulating material. Skin temperature of the hand was recorded continuously.
The criteria for discontinuation of sedation and extubation of the trachea in the ICU were: absence of significant bleeding; haemodynamic stability; core temperature ജ37.0°C; and difference between core and peripheral temperatures Ͻ4°C. For the purposes of this study, an additional criterion was added: a TOF ratio of at least 0.8 (the currently accepted standard for adequate antagonism of neuromuscular block 4 ) for three consecutive measurements. ICU nursing and medical staff were not informed of the results of the measurements unless the TOF ratio was less than 0.8 at the time when they wished to stop sedation. If the TOF ratio was less than 0.8, the investigator informed the attendant staff and the infusion of propofol and mechanical ventilation were continued until a satisfactory TOF ratio was recorded. Neuromuscular monitoring and sedation were then stopped and the trachea was extubated as clinically appropriate. Results are summarized in Table 1 . Eighteen patients underwent coronary artery revascularization and two patients underwent aortic valve replacement. The median dose of pancuronium was 0.11 mg kg -1 (interquartile range 0.10-0.14 mg kg -1 ). Six patients received an incremental dose of pancuronium during surgery. Nine patients were actively cooled during CPB. There was no significant correlation between the extent of residual neuromuscular block and the minimum temperature to which patients were cooled or administration of an incremental dose of pancuronium during CPB.
Comment
In spite of having received only relatively modest doses of pancuronium (median 0.11 mg kg -1 ), 13 of 20 patients demonstrated a considerable degree of residual block (median TOFϭ0.23) at the time the ICU staff expressed their desire to stop infusion of propofol used for sedation before extubation of the trachea. This decision was made when the patient was adequately re-warmed and there was no evidence of haemorrhage or haemodynamic instability. At this point, the group of 13 patients who demonstrated a significant degree of residual paralysis had been in the ICU for more than 2 h: an 339 additional 2 h 5 min (median) elapsed before neuromuscular function was satisfactory (Table 1) .
A recent study by Berg and colleagues 2 demonstrated the importance of avoiding residual neuromuscular block if postoperative pulmonary complications are to be minimized. After the use of pancuronium, significantly more patients with residual block developed postoperative pulmonary complications (16.9%) compared with patients in whom there was no residual block (4.8%). A TOF ratio of less than 0.7 was one of the predominant risk factors for the development of postoperative pulmonary complications in their study.
Six patients received an incremental dose of pancuronium at the start of CPB. Buzello and colleagues 5 demonstrated in 1985 that pancuronium-induced neuromuscular block was augmented by hypothermic CPB and its duration of action increased 1.8 fold. Even during normothermic perfusion, the duration of action of pancuronium was still 1.5 times longer than before bypass. They concluded that this was a result of a pharmacodynamic effect at the neuromuscular junction rather than a change in drug disposition.
Pancuronium continues to be favoured for cardiac anaesthesia because of its tendency to increase heart rate and arterial pressure which may be valuable in counteracting the cardiodepressant effects of anaesthetic agents. Nevertheless, it is possible to replace pancuronium with drugs of shorter duration, such as rocuronium, atracurium or cisatracurium, without apparent problems. We suggest that neuromuscular monitoring should be instituted as part of postoperative care in the cardiac ICU to avoid the common hazard of residual neuromuscular block. In particular, it should be routine practice to ensure that an adequate TOF ratio has been achieved before the decision is made to discontinue sedation and allow the patient to recover consciousness after cardiac surgery. Because simple tactile assessment of the TOF response is notoriously inaccurate, a more objective method of measurement such as acceleromyography may be appropriate. 6 
